Median Technologies SA (EPA:ALMDT)

France · Delayed Price · Currency is EUR

4.680

+0.180 (4.00%)

Aug 21, 2026, 5:35 PM CET

84.25% (1Y)

Market Cap	178.61M +102.7%
Revenue (ttm)	23.47M +2.2%
Net Income	-34.07M
EPS	-0.93
Shares Out	38.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	180,284
Open	4.620
Previous Close	4.500
Day's Range	4.555 - 4.710
52-Week Range	2.260 - 7.270
Beta	0.51
Analysts	Strong Buy
Price Target	11.97 (+155.77%)
Earnings Date	Sep 17, 2026

About Median Technologies

Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2002

Employees 199

Stock Exchange Euronext Paris

Ticker Symbol ALMDT

Full Company Profile

Financial Performance

In 2025, Median Technologies's revenue was 23.47 million, an increase of 2.22% compared to the previous year's 22.96 million. Losses were -34.07 million, 35.0% more than in 2024.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for ALMDT stock is "Strong Buy." The 12-month stock price target is €11.97, which is an increase of 155.77% from the latest price.

Price Target

€11.97

(155.77% upside)

Analyst Consensus: Strong Buy

Stock Forecasts